ucsf banner
Left Navigation Pane Image
Department of Clinical Pharmacy

Faculty & Staff

A
Alldredge, Brian K., Pharm.D. Alldredge, Brian K., Pharm.D.

  • Current Title(s):
    • Clinical Professor, Department of Neurology, School of Medicine
    • Professor of Clinical Pharmacy
    • Vice Provost for Academic Affairs, School of Pharmacy
  • First Year on UCSF Faculty: 1985
  • Education:
    • Bachelor of Science, University of California, Los Angeles, 1980
    • Pharm.D., University of California, San Francisco, 1984
  • Licensure:
    • Licentiate in Pharmacy, 1984
  • Specialty:
    • Epilepsy
    • Neurology
    • Patient Safety
    • Pharmacogenetics

University of California, San Francisco, School of Pharmacy  C-152, Box 0622, 513 Parnassus Avenue, S-101, San Francisco, CA 94143-0401
Phone: (415)-514-0421,  Fax: (415)514-0200,  Email: brian.alldredge@ucsf.edu


Professional Biography
Brian Alldredge is a clinician-educator-researcher with research and clinical interests in epilepsy, seizure emergencies, pharmacogenomics and pharmacy education. He serves as Vice Provost-Academic Affairs for the UCSF and he holds joint appointments as a professor of clinical pharmacy in the School of Pharmacy and a clinical professor in the Department of Neurology in the School of Medicine.

In his role as Vice Provost-Academic Affairs, he is part of the Executive Vice Chancellor & Provost (EVCP) leadership team, overseeing all aspects of faculty and academic affairs, including the Chancellorís Council on Faculty Life, faculty development and advancement programs and initiatives, and supporting the EVCP and Chancellor in all their strategic and operational goals related to faculty and academics. His duties include supervision of the Office of Academic Affairs and executing all existing administrative, operational and strategic tasks.


Selected Peer-reviewed Publications

  • Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483
  • Alldredge BK, Kayser SR. Bending the curve toward increased use of generic drugs. JAMA Intern Med 2013;173:233-4.
  • Alldredge BK, Lowenstein DH. Status epilepticus related to alcohol abuse. Epilepsia 1993;34:1033-7.
  • Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opinion on Drug Safety 2003;2:233-47.
  • Alldredge BK. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999;53(Suppl 2):S68-S75. Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, Fields SM, Lowenstein DH, Alldredge BK. The stability of diazepam and lorazepam as used in the pre-hospital setting. American Journal of Emergency Medicine 1999;17:333-7.
  • Auerbach AD, Sehgal NL, Blegen MA, Maselli J, Alldredge BK, Vittinghoff E, Wachter RM. Effects of a multicentre teamwork and communication programme on patient outcomes: results from the Triad for Optimal Patient Safety (TOPS) project. BMJ Qual Saf. 2012 Feb; 21(2):118-26.
  • Riviello JJ, Claassen J, Laroche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013 Apr; 18(2):193-200.
  • Alldredge BK, Lowenstein DH. Status epilepticus: new concepts. Current Opinion in Neurology 1999;12:183-90. Aweeka FT, Gottwald MD, Gambertoglio JG, Wright TL, Boyer TD, Pollock AS, Eldon MA, Kugler AR, Alldredge BK. Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease. Epilepsia 1999;40:777-82.
  • Alldredge BK, Wall DB, Ferriero DM. Effect of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol 1995;12:213-6.
  • Alldredge BK, Gelb AM, Isaacs SM, Corry MD, O''Neil N, Gottwald MD, Ulrich SK, Neuhaus JM, Segal MR, Lowenstein DH. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001;345:631-7.
  • Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O''Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ; Epilepsy Phenome/Genome Project, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. Nature. 2013 Aug 11. PMID: 23934111
  • Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ, Shutter L, Sperling MR, Treiman DM, Vespa PM. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012 Aug; 17(1):3-23.
  • Alldredge BK, Knutsen AP, Ferriero DM. Anticonvulsant hypersensitivity syndrome: in vitro and clinical observations. Pediatr Neurol 1994;10:169-71.
  • Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-6.
  • Lowenstein DH, Alldredge BK, Allen F, Neuhaus J, Corry M, Gottwald M, O''Neil N, Ulrich SK, Isaacs SM, Gelb AM. The prehospital treatment of status epilepticus (PHTSE) study: design and methodology. Controlled Clinical Trials 2001;22:290-309.
  • Alldredge BK, Venteicher R, Calderwood TS. Stability of diazepam rectal gel in ambulance-like environments. American Journal of Emergency Medicine 2002;20:88-91.
A